Investors today birched Cochlear shares by close to 40% after a radical earnings update – their worst fall in 30 years.
Shares fall 1.2pc on healthcare rout; Cochlear ends at 10-year low; Treasury Wine restructure; CBA says FX hedging increasing ...
Stockhead on MSN
Biocurious: Why biotech’s big end of town has lost its mojo
Cochlear, CSL and Pro Medicus have been hard hit by disparate concerns, many of which investors suspect are structural rather ...
WA Gold Limited (ASX:WAU) has unveiled a robust economic profile for initial mining at its Abercromby gold project in WA with ...
Cochlear reaffirmed guidance for FY 2025 underlying net profit between $410 million and $430 million, though it expects to achieve the lower end of this range. The revision is driven by weaker ...
A leading analyst believes the historic selloff in Cochlear shares could present a unique buying opportunity. The post Down 43% this week, are Cochlear shares now the best bargain buy of the year?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results